search  
 


Home

Who are we?

Why
register?


Signup for
registration


Online registration

Log in to register
your trial


Search a trial

NRT en CCMO

Contact

NEDERLANDS





MetaRegister
van CCT (UK)


ISRCTN-Register
van CCT (UK)


Gait and balance in patients with an osteoporotic vertebral compression fracture: The effect of bracing.


- candidate number22294
- NTR NumberNTR5243
- ISRCTNISRCTN no longer applicable
- Date ISRCTN created
- date ISRCTN requested
- Date Registered NTR3-jun-2015
- Secondary IDsNL52978.068.15 METC152021
- Public TitleGait and balance in patients with an osteoporotic vertebral compression fracture: The effect of bracing.
- Scientific TitleThe effect of a spinal orthosis on gait and balance in patients with symptomatic osteoporotic vertebral compression fractures
- ACRONYMGait and balance in patients with OVCF
- hypothesisPilot study
- Healt Condition(s) or Problem(s) studiedOsteoporosis
- Inclusion criteria-Female;
-Age 60 years or older;
- Fully ambulatory subject (ability to perform a 15 meter walk test without walking aids);
-Symptomatic osteoporotic vertebral compression fracture;
-Presenting at emergency department MUMC;
- Willing and able to provide informed consent.
- Exclusion criteria-Male;
-Unstable vertebral fractures requiring surgery;
-Fractures due to high energetic trauma;
-Neurologic deficit, active cancer;
-Alcohol or drugs use affecting balance or influencing central nervous system (within 48 hours before testing);
-History of neurogenic or myopathic disorders impairing sensory or motor functions;
-Psychiatric or mental disease;
-Insufficient cognitive or language skills to complete questionnaires.
- mec approval receivedno
- multicenter trialno
- randomisedno
- group[default]
- Type[default]
- Studytype[default]
- planned startdate 1-jul-2015
- planned closingdate
- Target number of participants15
- InterventionsAll subjects are prescribed to wear the thoracolumbar orthosis Osteolind® plus (Werkmeister, Wanfried, Germany) in the acute stage (the first six weeks after presentation at the Emergency department) for the entire day (during the night is optional). In the subacute stage (week six of disease onset) the subjects will be requested to wear the Osteolind® plus orthosis at least 6 hours daily, and after three months for at least 3 hours daily until the final follow-up at six months.
- Primary outcomeThe main study parameter is the assessment of margins of stability (MOS) at baseline, at six weeks and at six months follow-up. The patients will walk in a Computer Assisted Rehabilitation ENvironment (CAREN). The effects of walking with and without orthosis will be assessed on ‘Margins Of Stability’ (MOS). The MOS is defined as the distance between a velocity adjusted or ‘extrapolated’ position of the center of mass (XcoM) and the edge of an individiual’s base of support (BOS) at any given instant in time. The MOS is directly related to the impulse (I) required that causes instability. Center of mass (COM) position will be estimated as the average position of the four pelvis markers (right and left anterior and superior iliac spine).
- Secondary outcome1. To assess the effect of the Osteolind® plus orthosis on gait parameters, such as walking velocity, cadence, step time, and step length;
2. To assess the effect of the Osteolind® plus orthosis on quality of life (VAS, Tinetti scale, Qualeffo-41);
3. To assess the effect of the Osteolind® plus orthosis on sagittal alignment as determined on plain radiographs;
4. To assess the effect of the Osteolind® plus orthosis on trunk motion.
5. To assess the effect of the Osteolind® plus orthosis on the incidence of falls.
- Timepoints1 week, 6 weeks and 6 months after visit at ER
- Trial web site
- status[default]
- CONTACT FOR PUBLIC QUERIESMD Eva Jacobs
- CONTACT for SCIENTIFIC QUERIES
- Sponsor/Initiator Maastricht University Medical Center (MUMC+)
- Funding
(Source(s) of Monetary or Material Support)
None
- Publications
- Brief summary
- Main changes (audit trail)
- RECORD3-jun-2015 - 15-aug-2015


  • Indien u gegevens wilt toevoegen of veranderen, kunt u een mail sturen naar nederlands@trialregister.nl